By Research and Markets
Publication Date: 2025-11-24 14:18:00
AI in clinical trials offers significant opportunities by increasing efficiency, shortening timelines and enabling precision medicine. Key prospects include improved patient recruitment, protocol design and study workflows using ML, NLP and predictive analytics. Increases will be driven by adoption trends, regional dynamics and technological advances.
Artificial intelligence (AI) in the clinical trial market
Dublin, November 24, 2025 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI) in the Clinical Trials Market” report has been updated ResearchAndMarkets.com Offer.
The global artificial intelligence (AI) market in clinical trials was valued at $2 billion in 2024 and is expected to grow from $2.4 billion in 2025 to $6.5 billion in 2030, at a compound annual growth rate (CAGR) of 22.6% from 2025 to 2030.
The report examines trends in the global AI in clinical care market…
